[{"Assets_0_Q2_USD":1639443000.0,"CommonStockSharesOutstanding_0_Q2_shares":205630980.0,"EarningsPerShareBasic_1_Q2_USD":-0.06,"EarningsPerShareBasic_2_Q2_USD":-1.0,"EarningsPerShareDiluted_1_Q2_USD":-0.06,"EarningsPerShareDiluted_2_Q2_USD":-1.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-56844000.0,"StockholdersEquity_0_Q2_USD":1026835000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":205141000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":200200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":205141000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":200200000.0,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20170801"}]